Keywords: USA, PhRMA, Drug prices, Rebates, Medicare

USA’s PhRMA refutes NYT story on drug prices

Article | 18 November 2009

Pharmaceutical Research and Manufacturers of America (PhRMA), the USA drug industry lobby group, has strongly contested the allegations in a front page New York Times story that suggested that drugmakers raised their prices by 9% this year in order to cushion themselves from the steep cuts in drug spending that are included in the country’s health reform plans. That will add more than $10 billion to the nation’s drug bill, which is on track to exceed $300 billion this year. By at least one analysis, it is the highest annual rate of inflation for drug prices since 1992, the NYT article claimed.

T Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in